News Category: Regulatory news
We have published a Q&A document relating to the impact of the Windsor Framework on the regulation of human medicines. The document is based on questions the HPRA has received from companies.
Further questions on this topic can be sent to brexit@hpra.ie. We will update the document as necessary.
See the Brexit section of our website for further updates.